These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9834251)

  • 81. New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.
    Fletcher A; Bryant JA; Gardner B; Judson PA; Spring FA; Parsons SF; Mallinson G; Anstee DJ
    Immunology; 1992 Mar; 75(3):507-12. PubMed ID: 1374058
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
    Mevorach D
    Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
    Telen MJ
    Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Rare event counting of CD59- red cells in human blood: A 47-month experience using PNH consensus guidelines for WBC and RBC testing in a reference lab.
    Liew M; Farley M; Andreasen J; Parker CJ; Wittwer CT
    Cytometry B Clin Cytom; 2015; 88(4):261-9. PubMed ID: 25605539
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T
    Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
    Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
    Terpos E; Sarantopoulos A; Kouramba A; Katsarou O; Stavropoulos J; Masouridi S; Karafoulidou A; Meletis J
    Med Sci Monit; 2008 May; 14(5):CR276-280. PubMed ID: 18443552
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reticulocyte-gated flow cytometric analysis of red blood cells in paroxysmal nocturnal hemoglobinuria.
    Sato S; Hasegawa Y; Nagasawa T; Ninomiya H
    Lab Hematol; 2006; 12(2):82-5. PubMed ID: 16751135
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
    Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
    Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Rapid diagnosis of paroxysmal nocturnal hemoglobinuria by gel test agglutination].
    Navenot JM; Bernard D; Petit-Frioux Y; Loirat MJ; Guimbretière J; Muller JY; Blanchard D
    Rev Fr Transfus Hemobiol; 1993 Apr; 36(2):135-47. PubMed ID: 7684909
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.
    Saifuddin M; Parker CJ; Peeples ME; Gorny MK; Zolla-Pazner S; Ghassemi M; Rooney IA; Atkinson JP; Spear GT
    J Exp Med; 1995 Aug; 182(2):501-9. PubMed ID: 7543140
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Glycosilphosphatidylinositol-anchored cell surface protein deficiency in Mexican mestizo patients with aplastic anemia].
    Ruiz-Argüelles GJ; Ramírez Cisneros FJ; Ruiz-Argüelles A; Pérez-Romano B; Morales-Aceves R
    Rev Invest Clin; 1999; 51(1):5-9. PubMed ID: 10344161
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Detection of paroxysmal nocturnal hemoglobinuria-phenotype in patients with chronic lymphocytic leukemia and multiple myeloma.
    Varma S; Varma N; Reddy VV; Naseem S; Bose P; Malhotra P
    Indian J Pathol Microbiol; 2012; 55(2):206-10. PubMed ID: 22771645
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A prospective comparison of four techniques for diagnosis of paroxysmal nocturnal hemoglobinuria.
    Gupta R; Pandey P; Choudhry R; Kashyap R; Mehrotra M; Naseem S; Nityanand S
    Int J Lab Hematol; 2007 Apr; 29(2):119-26. PubMed ID: 17474884
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The effects of marathon running on expression of the complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood cells.
    Simpson RJ; Florida-James GD; Whyte GP; Middleton N; Shave R; George K; Guy K
    Eur J Appl Physiol; 2007 Jan; 99(2):201-4. PubMed ID: 17089158
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
    Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
    Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype.
    Shichishima T; Saitoh Y; Terasawa T; Noji H; Kai T; Maruyama Y
    Br J Haematol; 1999 Feb; 104(2):303-6. PubMed ID: 10050712
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Characterization of the complement sensitivity of calcium loaded human erythrocytes.
    Test ST; Bütikofer P; Yee MC; Kuypers FA; Lubin B
    Blood; 1991 Dec; 78(11):3056-65. PubMed ID: 1720041
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes.
    Mahoney JF; Urakaze M; Hall S; DeGasperi R; Chang HM; Sugiyama E; Warren CD; Borowitz M; Nicholson-Weller A; Rosse WF
    Blood; 1992 Mar; 79(6):1400-3. PubMed ID: 1372185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.